Daily WebLogs

Email, Print, Share. CLICK HERE.

Monsanto held liable for cancer-causing Roundup

Aug 20, 2018

There has been a long battle between Monsanto’s scientists who say that Roundup is perfectly safe and other scientists who say that Roundup is a very bad carcinogen. In this court case the judge was at first skeptical, but he was convinced by the scientists who opposed Roundup. He ruled against Monsanto on August 10, 2018. Of course, the case will be appealed, so the battle is not yet over. Hopefully, Dewayne Johnson will live to see the final verdict.


SAN FRANCISCO — A jury ordered chemical giant Monsanto to pay $289 million Friday to a school groundskeeper who got terminal cancer after using Roundup, one of the world's most popular weed killers.

The Superior Court jury deliberated for two and a half days before finding that Dewayne Johnson's non-Hodgkin lymphoma was at least partly due to using glyphosate, the primary ingredient in Roundup. Johnson regularly used glyphosate to spray fields while working as a groundskeeper.

Monsanto "acted with malice, oppression or fraud and should be punished for its conduct," Judge Suzanne Ramos Bolanos announced in court….

Hundreds of lawsuits claiming Roundup causes cancer have been given the green light to proceed to trial, despite Monsanto claims that there is no connection between glyphosate and cancer.

Cancer victims and families presenting cases say Monsanto knew about the ingredient's risk for years, but failed to warn buyers. U.S. District Judge Vince Chhabria had previously said there's “rather weak" evidence the ingredient causes cancer, but the opinions of three experts linking glyphosate and non-Hodgkin’s lymphoma were not “junk science…."

In the past, Monsanto sued California’s Office of Environmental Health Hazard Assessment for adding glyphosate to a list of cancer causing chemicals, and lost.

Here is a 2-minute video from one organization that has been fighting Roundup for a long time.


Not long ago, Monsanto was bought by Bayer, the German drug company. Bayer’s stock dropped from $27 to $23 on the news.

Sharing / Blog Info

Category: In The News
Blog Author: Dr. Stephen Jones